The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-UK's Johnson looks for path out of lockdown after 15 million vaccinated

Mon, 15th Feb 2021 07:43

* UK hits 15 million vaccination target

* UK PM Johnson to judge this week on lockdown exit

* UK looking at vaccine certificates to help Britons travel

* Hotel quarantine is going smoothly, minister says
(Adds calls for lockdown to end)

By Guy Faulconbridge and Kate Holton

LONDON, Feb 15 (Reuters) - British Prime Minister Boris
Johnson will judge this week how fast England can exit COVID-19
lockdown after vaccinating 15 million of its most vulnerable
people, but the health minister said death and hospital
admission numbers were still too high.

With nearly a quarter of the United Kingdom's population now
inoculated with a first dose of a COVID vaccine in a little over
two months, Johnson is under pressure from some lawmakers and
businesses to reopen the shuttered economy.

"We've got to watch the data," Health Secretary Matt Hancock
told Sky News. "Everybody wants to get out of this as quickly as
we safely can, and both as quickly, but also as safely, are
important.

"The question is a judgment of how quickly and safely, how
quickly we can do that safely. That's the judgment that we're
making this week, looking at the data, ahead of the prime
minister setting out the roadmap, on the 22nd," he said.

The biggest and swiftest global vaccine rollout in history
is seen as the best chance of exiting the COVID-19 pandemic
which has killed 2.4 million people, tipped the global economy
into its worst peacetime slump since the Great Depression and
upended normal life for billions.

Britain has vaccinated 15.062 million people with a first
dose and 537,715 with a second dose, the fastest rollout per
capita of any large country. Hancock said he expected vaccine
supplies to increase as manufacturing accelerated.

An influential group of lawmakers in Johnson's Conservative
Party are calling for the end of lockdown as soon as the most
vulnerable nine groups are vaccinated. They want no more rules
beyond May 1.

"We're all filled with sorrow for the people we've lost, the
harms that we've suffered but we don't honour those we've loved
and lost by wrecking the rest of our lives," lawmaker Steve
Baker said. "We've got to find a way to rebuild our society and
our economy and our prospects, our livelihoods."

Hancock said the British government was speaking to other
countries across the world about giving British people
certificates showing they had been vaccinated so that they could
travel abroad in the future to countries that require them.

"There is this international work going on because if other
countries require (proof of vaccination) we want to allow Brits
to be able to travel to those countries," Hancock said.

"We'd want to be able to facilitate that sort of vaccine
certification, but it isn't anything we're planning to introduce
here," he said, adding that a so-called vaccine passport was not
something that would be required to access services in the UK.

The United Kingdom has the world's fifth-worst official
death toll - currently 117,166 - after the United States,
Brazil, Mexico and India.

A new COVID-19 hotel quarantine system for arrivals from 33
"red list" countries, intended to limit the spread of new
variants of the virus, appeared to be working smoothly a few
hours after it was introduced, Hancock said.
(Reporting by Guy Faulconbridge and Kate Holton; Editing by
James Davey, Peter Graff and Nick Macfie)

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.